Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
10x Genomics, Inc. (TXG)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/24/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 3,757 shares
@ $45.7811, valued at
$172k
|
|
08/24/2023 |
4
| McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 1,678 shares
@ $45.7811, valued at
$76.8k
|
|
08/24/2023 |
4
| Wilbur James (Chief Commercial Officer) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 9,699 shares
@ $45.7811, valued at
$444k
|
|
08/24/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 3,449 shares
@ $45.7811, valued at
$157.9k
|
|
08/16/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 1,983 shares
@ $50.1033, valued at
$99.4k
Sold 17 shares
@ $50.42, valued at
$857.1 |
|
08/03/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 1,727 shares
@ $61.7714, valued at
$106.7k
Sold 5,243 shares
@ $62.3561, valued at
$326.9k
Exercised 6,970 options to buy
@ $11.48, valued at
$80k
|
|
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2023 |
4
| ROBERTS BRYAN E (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 1,865 shares
@ $0 Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
06/16/2023 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 1,865 shares
@ $0 Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
06/16/2023 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 1,865 shares
@ $0 Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
06/16/2023 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 1,865 shares
@ $0 Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
06/16/2023 |
4
| Mammen Mathai (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 1,865 shares
@ $0 Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
06/16/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 1,865 shares
@ $0 Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
06/16/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Gifted 185 shares
@ $0 Sold 740 shares
@ $57.5038, valued at
$42.6k
Sold 1,209 shares
@ $58.5262, valued at
$70.8k
Sold 51 shares
@ $59.15, valued at
$3k
|
|
06/07/2023 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 10,000 shares
@ $54.8894, valued at
$548.9k
|
|
05/25/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 243 shares
@ $55.0594, valued at
$13.4k
Sold 619 shares
@ $55.0605, valued at
$34.1k
Sold 735 shares
@ $55.0631, valued at
$40.5k
Sold 791 shares
@ $55.0612, valued at
$43.6k
|
|
05/25/2023 |
4
| Wilbur James (Chief Commercial Officer) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 316 shares
@ $55.0653, valued at
$17.4k
|
|
05/25/2023 |
4
| McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 194 shares
@ $55.0695, valued at
$10.7k
Sold 465 shares
@ $55.0621, valued at
$25.6k
Sold 441 shares
@ $55.0641, valued at
$24.3k
Sold 565 shares
@ $55.0637, valued at
$31.1k
|
|
05/23/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Gifted 460 shares
@ $0 Sold 534 shares
@ $55.064, valued at
$29.4k
Sold 2,068 shares
@ $55.0613, valued at
$113.9k
|
|
05/19/2023 |
4
| ROBERTS BRYAN E (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Converted 3,790,422 shares
@ $0 Converted 3,790,422 options to buy
@ $0 |
|
05/17/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 494 shares
@ $52.6971, valued at
$26k
Sold 1,506 shares
@ $53.5652, valued at
$80.7k
|
|
05/15/2023 |
4
| Mammen Mathai (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 33,000 shares
@ $52.8208, valued at
$1.7M
Exercised 200,000 options to buy
@ $1.16, valued at
$232k
|
|
04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2023 |
4
| McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 25,991 shares
@ $0 Granted 25,991 options to buy
@ $50.1, valued at
$1.3M
Granted 12,996 options to buy
@ $0 |
|
03/23/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 36,387 shares
@ $0 Granted 36,387 options to buy
@ $50.1, valued at
$1.8M
Granted 18,194 options to buy
@ $0 |
|
03/23/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 36,387 shares
@ $0 Granted 72,773 options to buy
@ $50.1, valued at
$3.6M
Granted 72,773 options to buy
@ $0 |
|
03/23/2023 |
4
| Wilbur James (Chief Commercial Officer) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Granted 14,555 shares
@ $0 Granted 14,555 options to buy
@ $50.1, valued at
$729.2k
Granted 7,278 options to buy
@ $0 |
|
03/16/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 1,697 shares
@ $48.806, valued at
$82.8k
Sold 303 shares
@ $49.2808, valued at
$14.9k
|
|
03/09/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Gifted 260 shares
@ $0 |
|
02/24/2023 |
4
| McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 1,245 shares
@ $47.7533, valued at
$59.5k
|
|
02/24/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 1,742 shares
@ $47.7533, valued at
$83.2k
|
|
02/24/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Sold 1,941 shares
@ $47.7533, valued at
$92.7k
|
|
|
|
|